首页|抗新冠病毒木瓜样蛋白酶原核表达条件优化及多克隆抗体的制备与鉴定

抗新冠病毒木瓜样蛋白酶原核表达条件优化及多克隆抗体的制备与鉴定

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
目的:优化新型冠状病毒木瓜样蛋白酶(papain-like protease,PLpro)在大肠杆菌中的表达条件,并制备高特异性大鼠抗PLpro多克隆抗体.方法:通过优化诱导时间、诱导温度和IPTG诱导浓度,确定PLpro在大肠杆菌中的最佳表达条件,以HisTrapTM亲和层析柱分离纯化PLpro后,将其作为抗原免疫大鼠,制备抗PLpro 多克隆抗体,以酶联免疫吸附实验(Enzyme-linked immunosorbent assay,ELISA)和蛋白免疫印迹实验(Western blot)测定多克隆抗体的效价、抗原特异性和灵敏性.结果:PLpro 最佳诱导温度为 20℃、诱导时间为 10 h、IPTG 浓度为0.2 mmol/L;抗PLpro多克隆抗体的效价可达 1∶256 000,且具有良好的抗原特异性;抗PLpro多克隆抗体对抗原的检测限可达 12.5 ng,具有良好的灵敏性.结论:本研究成功地进行了PLpro在大肠杆菌中的表达条件优化及高特异性大鼠抗PLpro多克隆抗体的制备,为研究PLpro在新冠肺炎中的免疫学功能奠定了基础.
Optimization of prokaryotic expression condition of SARS-CoV-2 papain-like protease and preparation and identification of polyclonal antibody
Objective:To optimize the expression conditions of SARS-CoV-2 papain-like protease(papain-like protease,PLpro)in Escherichia coli(E.coli)and prepare highly specific polyclonal antibody against rat PLpro.Meth-ods:The optimal expression conditions of PLpro in E.coli were determined by optimizing induction time,induction temper-ature and IPTG concentration.After PLpro being isolated and purified by HisTrapTM affinity chromatography column,the rat was immunized with Plpro as antigen to prepare anti-Plpro polyclonal antibody.The titer,antigen specificity and sensitivity of polyclonal antibody were determined by enzyme-linked immunosorbent assay(ELISA)and Western Blot ex-periments.Results:The optimum induction temperature of Plpro was 20℃,the induction time was 10 h,and the concen-tration of IPTG was 0.2 mmol/L.The titer of anti-Plpro polyclonal antibody reached to 1∶256 000 with good antigen specificity,and the detection limit of anti-Plpro polyclonal antibody was 12.5 ng with good sensitivity.Conclusion:The expression conditions of Plpro in E.coli was successfully optimized and highly specific polyclonal antibody against rat PL-pro successfully prepared,which laid a foundation for the study of the immunological function of Plpro in COVID-19.

SARS-CoV-2Papain-like proteaseProkaryotic expressionCondition optimizationELISAPolyclonal antibody

刘志成、闫干干、闫浩浩、刘晓丽、刘晓平、陈云雨

展开 >

皖南医学院药物评价与筛选研究所,安徽 芜湖 241000

新型冠状病毒 木瓜样蛋白酶(PLpro) 原核表达 条件优化 酶联免疫吸附实验 多克隆抗体

国家自然科学基金安徽省自然科学基金安徽省高等学校自然科学研究项目安徽省高等学校自然科学研究项目安徽省高等学校自然科学研究项目皖南医学院青年骨干人才资助项目

817035461808085QH265KJ2019ZD30KJ2021A0839YJS20210549wyqnyx202104

2024

10.16833/j.cnki.jbmc.2024.01.015

包头医学院学报
内蒙古科技大学包头医学院

包头医学院学报

影响因子：0.543
ISSN：1006-740X
年,卷(期)：2024.40(1)
  • 10